A Service of the National Health Information Center, U.S. Department of Health & Human Services
	Help | Advanced Search News Library Just For You Health Care Organizations en Español

Hydrazine Sulfate (PDQ®) Internet URL http://www.cancer.gov/cancer_information/doc.aspx?viewid=25FB1A5E-DDFD-4B67-8ECE-B6C62B9A17CD Sponsoring Agency National Cancer Institute, National Institutes of Health Description The summary includes a brief history of hydrazine sulfate research, results of clinical trials, and possible side effects of hydrazine sulfate use. Hydrazine sulfate is a monoamine oxidase (MAO) inhibitor that has been investigated for more than 30 years as a treatment for cancer and as a therapy to decrease cancer-related anorexia (inability to eat) and cachexia (muscle wasting). Related Topics Alternative Medicine Cancer Complementary Medicine Review Date 6/15/2004

	About Us Accessibility Disclaimer Freedom of Information Act Privacy Contact Us Office of Disease Prevention and Health Promotion, U.S. Department of Health & Human Services